Skip to main content
. 2023 Jan 23;51(1):447–456. doi: 10.1042/BST20221343

Figure 3. Timeline of notable RAS drug development events since 2007.

Figure 3.

Arrowheads mark publications of binders and sites with colours corresponding to those used for binding sites in Figures 1 and 2.